|144.30||+0.7100||+0.49%||Vol 524.30K||1Y Perf -13.17%|
|Jan 14th, 2022 16:00 DELAYED|
|- -||0.70 0.49%|
|Target Price||202.31||Analyst Rating||Strong Buy 1.21|
|Potential %||40.20||Finscreener Ranking||★★★★ 52.12|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 47.73|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★+ 43.91|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||37.36||Earnings Rating||Strong Buy|
|Market Cap||8.87B||Earnings Date||22nd Feb 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||22nd Feb 2022|
|Estimated EPS Next Report||2.87|
|EPS Growth Next 5 Years %||13.80|
|Avg. Weekly Volume||1.11M|
|Avg. Monthly Volume||666.44K|
|Avg. Quarterly Volume||603.70K|
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stock closed at 144.3 per share at the end of the most recent trading day (a 0.49% change compared to the prior day closing price) with a volume of 527.31K shares and market capitalization of 8.87B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1940 people. Jazz Pharmaceuticals plc CEO is Bruce C. Cozadd.
The one-year performance of Jazz Pharmaceuticals plc stock is -13.17%, while year-to-date (YTD) performance is 13.27%. JAZZ stock has a five-year performance of 23.02%. Its 52-week range is between 117.64 and 189, which gives JAZZ stock a 52-week price range ratio of 37.36%
Jazz Pharmaceuticals plc currently has a PE ratio of -53.10, a price-to-book (PB) ratio of 2.10, a price-to-sale (PS) ratio of 4.10, a price to cashflow ratio of 10.00, a PEG ratio of 2.32, a ROA of -1.72%, a ROC of -0.02% and a ROE of -4.42%. The company’s profit margin is -13.39%, its EBITDA margin is 26.30%, and its revenue ttm is $2.20 Billion , which makes it $35.75 revenue per share.
Of the last four earnings reports from Jazz Pharmaceuticals plc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $2.87 for the next earnings report. Jazz Pharmaceuticals plc’s next earnings report date is 22nd Feb 2022.
The consensus rating of Wall Street analysts for Jazz Pharmaceuticals plc is Strong Buy (1.21), with a target price of $202.31, which is +40.20% compared to the current price. The earnings rating for Jazz Pharmaceuticals plc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Jazz Pharmaceuticals plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Jazz Pharmaceuticals plc has a Buy technical analysis rating based on Technical Indicators (ADX : 9.09, ATR14 : 4.38, CCI20 : 117.22, Chaikin Money Flow : 0.12, MACD : 4.61, Money Flow Index : 73.31, ROC : 9.71, RSI : 66.37, STOCH (14,3) : 70.58, STOCH RSI : 0.34, UO : 55.62, Williams %R : -29.42), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Jazz Pharmaceuticals plc in the last 12-months were: Bruce C. Cozadd (Option Excercise at a value of $1 941 197), Bruce C. Cozadd (Sold 44 293 shares of value $6 431 027 ), Catherine A. Sohn (Sold 1 306 shares of value $193 236 ), Elmar Schnee (Sold 1 632 shares of value $251 328 ), Heather Ann McSharry (Sold 1 414 shares of value $209 215 ), Jennifer Cook (Sold 417 shares of value $50 582 ), Kenneth W. O'Keefe (Sold 1 306 shares of value $193 236 ), Kim Sablich (Sold 2 748 shares of value $371 000 ), Norbert G. Riedel (Sold 1 306 shares of value $193 236 ), Patricia Carr (Sold 4 257 shares of value $685 609 ), Paul L. Berns (Sold 1 450 shares of value $223 300 ), Peter P. Gray (Sold 1 414 shares of value $209 215 ), Rick E. Winningham (Sold 1 306 shares of value $193 236 )
Tue, 16 Nov 2021 11:15 GMT Analysts Top Healthcare Picks: Jazz Pharmaceuticals (JAZZ), Altimmune (ALT)- TipRanks. All rights reserved.
Tue, 19 Oct 2021 11:37 GMT Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), BiomX (PHGE)- TipRanks. All rights reserved.
Mon, 16 Aug 2021 10:25 GMT Analysts Top Healthcare Picks: Jazz Pharmaceuticals (JAZZ), Biohaven Pharmaceutical Holding Co (BHVN)- TipRanks. All rights reserved.
Thu, 12 Aug 2021 08:39 GMT What Investors Can Learn from Jazz Pharmaceuticals Newly Added Risk Factors- TipRanks. All rights reserved.
Tue, 10 Aug 2021 09:41 GMT Jazz Pharmaceuticals (JAZZ) Receives a Buy from RBC Capital- TipRanks. All rights reserved.
Thu, 05 Aug 2021 07:23 GMT Jazz Pharmaceuticals (JAZZ) Received its Third Buy in a Row- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.